Pedro-Botet J - Search Results

1

[Testosterone deficiency, metabolic syndrome and diabetes mellitus].

Fernández-Miró M, Chillarón JJ, Pedro-Botet J. Fernández-Miró M, et al. Med Clin (Barc). 2016 Jan 15;146(2):69-73. doi: 10.1016/j.medcli.2015.06.020. Epub 2015 Oct 1. Med Clin (Barc). 2016. PMID: 26433309 Review. Spanish.

2

Estimated glucose disposal rate in assessment of the metabolic syndrome and microvascular complications in patients with type 1 diabetes.

Chillarón JJ, Goday A, Flores-Le-Roux JA, Benaiges D, Carrera MJ, Puig J, Cano-Pérez JF, Pedro-Botet J. Chillarón JJ, et al. J Clin Endocrinol Metab. 2009 Sep;94(9):3530-4. doi: 10.1210/jc.2009-0960. Epub 2009 Jul 7. J Clin Endocrinol Metab. 2009. PMID: 19584183

3

[Metabolic syndrome and type-1 diabetes mellitus: prevalence and associated factors].

Chillarón JJ, Flores-Le-Roux JA, Goday A, Benaiges D, Carrera MJ, Puig J, Cano-Pérez JF, Pedro-Botet J. Chillarón JJ, et al. Rev Esp Cardiol. 2010 Apr;63(4):423-9. Rev Esp Cardiol. 2010. PMID: 20334808 Free article. Spanish.

4

Prevalence and related factors with the presence of albuminuria and its stages in patients with type 1 diabetes mellitus.

Chillarón JJ, Flores-Le-Roux JA, Sales MP, Puig-de-Dou J, Castells I, Benaiges D, Pedro-Botet J. Chillarón JJ, et al. Nefrologia. 2013;33(2):231-6. doi: 10.3265/Nefrologia.pre2012.Oct.11643. Nefrologia. 2013. PMID: 23511759 Free article. English, Spanish.

5

[Atherogenic dyslipidemia in patients with type 1 diabetes mellitus].

Chillarón JJ, Sales MP, Flores Le-Roux JA, Castells I, Benaiges D, Sagarra E, Pedro-Botet J. Chillarón JJ, et al. Med Clin (Barc). 2013 Dec 7;141(11):465-70. doi: 10.1016/j.medcli.2013.03.016. Epub 2013 Jun 19. Med Clin (Barc). 2013. PMID: 23790581 Spanish.

6

Type 1 diabetes, metabolic syndrome and cardiovascular risk.

Chillarón JJ, Flores Le-Roux JA, Benaiges D, Pedro-Botet J. Chillarón JJ, et al. Metabolism. 2014 Feb;63(2):181-7. doi: 10.1016/j.metabol.2013.10.002. Epub 2013 Oct 24. Metabolism. 2014. PMID: 24274980 Review.

7

Age, insulin requirements, waist circumference, and triglycerides predict hypogonadotropic hypogonadism in patients with type 1 diabetes.

Chillarón JJ, Fernández-Miró M, Albareda M, Vila L, Colom C, Fontserè S, Pedro-Botet J, Flores-Le Roux JA; TEST-DM1 Study Group. Chillarón JJ, et al. J Sex Med. 2015 Jan;12(1):76-82. doi: 10.1111/jsm.12748. Epub 2014 Nov 13. J Sex Med. 2015. PMID: 25394376

8

[Dapagliflozin: Beyond glycemic control in the treatment of type 2 diabetes mellitus].

Sanz-Serra P, Pedro-Botet J, Flores-Le Roux JA, Benaiges D, Chillarón JJ. Sanz-Serra P, et al. Clin Investig Arterioscler. 2015 Jul-Aug;27(4):205-11. doi: 10.1016/j.arteri.2014.11.001. Epub 2015 Jan 31. Clin Investig Arterioscler. 2015. PMID: 25648671 Review. Spanish.

9

[Cardiovascular prevention in diabetes mellitus: A multifactorial challenge].

Pedro-Botet J, Chillarón JJ, Benaiges D, Flores-Le Roux JA. Pedro-Botet J, et al. Clin Investig Arterioscler. 2016 May-Jun;28(3):154-63. doi: 10.1016/j.arteri.2015.10.003. Epub 2015 Dec 2. Clin Investig Arterioscler. 2016. PMID: 26655375 Review. Spanish.

10

Testosterone undecanoate improves lipid profile in patients with type 1 diabetes and hypogonadotrophic hypogonadism.

Chillarón JJ, Fernández-Miró M, Albareda M, Fontserè S, Colom C, Vila L, Pedro-Botet J, Flores Le-Roux JA. Chillarón JJ, et al. Endocr J. 2016 Sep 30;63(9):849-855. doi: 10.1507/endocrj.EJ16-0195. Epub 2016 Jul 22. Endocr J. 2016. PMID: 27452372 Free article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

357 results

Search Page

Filters